Jane Wright Mitchell

General Counsel, AcelRx Pharmaceuticals (United States).

Companies

Vera Therapeutics, Inc.General counsel Mar 25, 2026 to now¹
Vaxcyte, Inc.General counsel Jun 11, 2020 to Aug 18, 2021²
AcelRx Pharmaceuticals (United States)General counsel Jul 23, 2014 to Feb 9, 2017³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Vera Therapeutics, Inc. VERA42,403 shares⁴$1.2M at $28.43Mar 23, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 23, 2026Granted 42,403 shares of Vera Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVera Therapeutics, Inc., General counsel
2
SEC EDGARVaxcyte, Inc., General counsel
3
SEC EDGARAcelRx Pharmaceuticals (United States), General counsel
4
SEC EDGARVera Therapeutics, Inc. shares after the filing of Mar 23, 2026